The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 528 KB) and Technical Notes (PDF, 794 KB) pages.

Download and Print: Download Printer-friendly PDF Download data

Table 1.22

U.S. Complete Prevalence Counts, Invasive Cancers Only, January 1, 2017a
By Age at Prevalence

Site Sex Age at Prevalence
All Agesc Ages
0-9		 Ages
10-19		 Ages
20-29		 Ages
30-39		 Ages
40-49		 Ages
50-59		 Ages
60-69		 Ages
70+
All Sites Males 7,230,811 18,934 46,984 94,237 173,576 326,188 902,270 1,935,304 3,733,319
Females 8,530,128 17,349 39,559 94,470 259,031 636,411 1,465,468 2,240,404 3,777,436
Oral Cavity & Pharynx Males 259,578 80 482 1,460 3,675 12,709 49,144 87,698 104,331
Females 123,837 51 544 1,575 3,809 8,476 20,800 33,291 55,292
Esophagus Males 36,777 0 0 42 151 795 4,550 12,056 19,184
Females 10,912 0 0 20 65 253 1,097 3,206 6,272
Stomach Males 66,182 0 24 166 855 2,646 8,956 17,838 35,697
Females 50,343 0 34 194 930 2,690 7,429 12,178 26,888
Colon & Rectum Males 673,580 0 496 1,677 7,391 26,870 97,594 174,856 364,694
Females 674,507 23 682 2,187 7,535 26,276 87,486 150,342 399,977
Liver & Intrahepatic Bile Duct Males 62,044 655 798 587 548 1,709 10,458 29,467 17,822
Females 27,905 590 662 429 612 1,187 4,084 9,773 10,570
Pancreas Males 39,194 15 73 94 564 1,763 6,302 12,922 17,461
Females 39,775 0 94 402 863 2,421 6,224 11,571 18,201
Larynx Males 78,873 5 0 95 280 1,443 8,601 22,512 45,936
Females 17,359 0 8 38 170 659 2,894 5,328 8,262
Lung & Bronchus Males 248,102 68 114 402 1,276 4,402 23,436 68,436 149,967
Females 310,148 76 61 490 1,539 5,870 32,698 79,250 190,163
Melanoma of the Skin Males 637,311 46 604 4,254 16,376 39,626 99,300 171,806 305,299
Females 607,965 117 750 7,851 32,663 66,779 126,153 154,077 219,573
Breast Males 20,067 0 0 4 165 519 2,262 4,978 12,140
Females 3,577,264 16 24 3,230 40,990 208,462 607,256 993,294 1,723,992
Cervix Females 291,704 0 41 1,728 14,721 40,501 66,065 73,541 95,106
Corpus & Uterus, NOS Females 793,846 6 14 838 7,570 29,736 102,263 234,589 418,829
Ovaryd Females 233,364 83 1,178 4,391 8,781 19,078 45,975 66,047 87,831
Prostate Males 3,170,339 24 52 62 160 12,636 211,872 862,584 2,082,949
Urinary Bladder Males 535,940 84 102 592 2,304 8,502 39,063 120,315 364,978
Females 176,673 41 66 252 1,015 2,920 13,121 36,108 123,151
Kidney & Renal Pelvis Males 341,611 1,528 2,135 2,586 9,504 22,714 56,901 96,822 149,421
Females 216,412 1,787 2,512 3,256 6,978 15,461 34,092 55,594 96,732
Hodgkin Lymphoma Males 110,766 177 2,445 10,164 15,563 21,243 26,759 21,198 13,218
Females 104,765 51 1,761 9,008 16,706 20,866 25,039 18,466 12,868
Non-Hodgkin Lymphoma Males 381,435 1,018 4,007 8,235 14,539 27,966 61,937 98,040 165,695
Females 338,396 508 1,908 4,789 10,313 21,172 49,161 85,062 165,484
Myeloma Males 77,901 0 16 71 715 3,571 11,603 24,109 37,814
Females 62,878 3 17 59 457 2,739 9,316 19,330 30,957
Leukemia Males 247,369 6,938 15,759 17,357 13,215 17,531 32,152 54,022 90,393
Females 187,613 6,288 12,094 14,087 11,579 14,414 23,064 35,985 70,102
Acute Lymphocytic Leukemia Males 54,552 5,780 13,274 13,580 8,828 7,000 3,705 1,625 760
Females 45,460 5,211 10,348 10,530 7,782 5,730 3,314 1,563 982

Footnotes:

a U.S. 2017 cancer prevalence counts are based on 2017 cancer prevalence proportions from the SEER 13 areas not including the Alaska Natives Registry (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta, Rural Georgia, San Jose-Monterey, and Los Angeles) and 1/1/2017 U.S. population estimates based on the average of 2016 and 2017 population estimates from the U.S. Bureau of the Census. Prevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 25 years.

b Cases diagnosed more than 25 years ago were estimated using the completeness index method (Capocaccia et. al. 1997, Merrill et. al. 2000).

c Due to rounding, the sum of the age specific estimates may not equal the all ages estimate.

Page Navigation: << Previous Next >>

The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.